Cardiovascular disease

Coronary heart disease is a leading cause of death for Australian women, yet women have been less likely than men to receive key heart attack treatment, and are under-represented in the trials that shape care.

Coronary heart disease develops when fatty plaque builds up in the arteries that supply blood to the heart. A heart attack happens when an artery becomes blocked [7]. It is a leading cause of death for Australian women. In 2025 it was the second leading cause after dementia, with 5,965 women dying from it [1].

The gap is not only in who gets heart disease, but in how women are treated when they do. One study looked at nearly 2,900 people treated for a major heart attack at 41 Australian hospitals between 2009 and 2016. Women were about half as likely as men to have a coronary angiogram, a test that shows whether the heart’s arteries are narrowed or blocked. They were also less likely to be given key medicines when they left hospital, or to be referred to cardiac rehabilitation. They were about twice as likely to die within six months. These differences remained after the researchers allowed for how high-risk each patient was on arrival, using a standard score that includes age [2].

Symptoms are part of the story. Chest pain is the most common heart attack symptom in both women and men, but women under 50 more often have symptoms other than chest pain, such as pain in the jaw, shoulder or back, nausea, or breathlessness. The Heart Foundation’s guide to women’s risk factors and warning signs explains them [6].

5,965

Australian women who died from coronary (ischaemic) heart disease in 2025, about 16 a day. It was the second leading cause of death for women, after dementia. Preliminary data.
AustraliaSource 1

About half

Women's odds of having a coronary angiogram after a major heart attack, compared with men (odds ratio 0.53), at 41 Australian hospitals. The data covers 2009–2016.
AustraliaSource 2

2×

Women's odds of dying within six months of a major heart attack, compared with men (odds ratio 2.17), in the same 2009–2016 study.
AustraliaSource 2

41%

Share of participants who were women in 1,079 cardiovascular trials, 2017–2023. Women were most under-represented, relative to how common the disease is in women, in coronary heart disease, stroke and acute coronary syndrome trials.
GlobalSource 3

54%

Women who had never seen their doctor for a general heart health check. From the Her Heart 2023 National Report Card survey, as reported by the Heart Foundation.
AustraliaSource 4

Why it matters in Australia

The best-known Australian evidence on unequal heart attack care is now dated: it covers patients treated up to 2016. Newer data is more mixed. A 2024 study looked at 2,747 people in Queensland who had emergency stenting, a procedure to open a blocked heart artery, between 2017 and 2020. Women still waited longer for treatment, and fewer were treated within the 90-minute target (50% compared with 58%). After allowing for other factors, being a woman was not linked to a higher risk of dying within 30 days, or of dying from heart disease within a year [5]. Faster, more consistent care may be narrowing the gap, but delays remain, and there is no recent national picture.

Many women have never had their heart health checked. In a 2023 survey, more than half said they had never seen their doctor for a general heart health check [4]. A Medicare-funded Heart Health Check with a GP is available to people aged 45 and over, or 30 and over for First Nations people.

Global context

Women remain under-represented in the research that shapes heart care. Across 1,079 cardiovascular trials registered between 2017 and 2023, women made up 41% of participants. Compared with how common each condition is in women, they were least well represented in trials for coronary heart disease, stroke and acute coronary syndrome [3].

In numbers

From the In numbers page. Each chart lists its own source.

Australia2025

Coronary heart disease killed 5,965 Australian women in 2025. Breast cancer killed 3,244.

Deaths of Australian women from coronary heart disease and breast cancer, 2025Coronary heart disease: 5,965 deaths, shown as 60 figures. Breast cancer: 3,244 deaths, shown as 32 figures. One figure = 100 deaths.Coronary heart disease5,965 deaths · about 16 a dayBreast cancer3,244 deaths · about 9 a day
About 16 women a day died from coronary heart disease, and about 9 a day from breast cancer. Each figure stands for 100 deaths, rounded to the nearest 100.
Show the data
Australian women, deaths registered in 2025
Cause (ABS name)DeathsDeaths a dayYears of potential life lost
Ischaemic heart diseases (I20-I25)5,96516.313,959
Malignant neoplasm of breast (C50)3,2448.925,503

Deaths a day = deaths ÷ 365.

Breast cancer kills women younger, so it costs more years of life: 25,503 years of potential life lost, compared with 13,959 for coronary heart disease.

Source: ABS, Causes of Death, Australia, 2025. Data: abs_cod_2025_by_cause_sex.csv

Global2010–2025

Women are 35% of heart disease trial participants but carry 39% of the burden.

Half of heart disease trials are less than 28.5% women.

Women's share of trial participants vs women's share of the disease burden, by conditionAlzheimer's and other dementias: 58% of participants, 66% of burden; Low back pain: 57% of participants, 63% of burden; Anxiety disorders: 56% of participants, 61% of burden; Ischaemic heart disease: 35% of participants, 39% of burden; Stroke: 42% of participants, 45% of burden; Osteoarthritis: 62% of participants, 61% of burden; Depressive disorders: 63% of participants, 60% of burden; Rheumatoid arthritis: 79% of participants, 72% of burden; Migraine: 84% of participants, 69% of burden.Women's share of trial participantsWomen's share of the disease burden (DALYs, GBD 2023)Alzheimer's and other dementiasParticipants 58% · Burden 66%Low back painParticipants 57% · Burden 63%Anxiety disordersParticipants 56% · Burden 61%Ischaemic heart diseaseParticipants 35% · Burden 39%StrokeParticipants 42% · Burden 45%OsteoarthritisParticipants 62% · Burden 61%Depressive disordersParticipants 63% · Burden 60%Rheumatoid arthritisParticipants 79% · Burden 72%MigraineParticipants 84% · Burden 69%0%25%50%75%100%
Women's share of trial participants was below their share of the disease burden in 5 of 9 conditions. The biggest shortfall was in Alzheimer's and other dementias (58% of participants, 66% of the burden).
Show the data
Women's share of trial participants and of the disease burden, by condition (sorted by the gap)
ConditionTrialsWomen, all participantsWomen, median trialWomen, share of burden
Alzheimer's and other dementias86258.4%55.6%65.6%
Low back pain23056.5%55.4%62.5%
Anxiety disorders60055.6%63.0%60.9%
Ischaemic heart disease68434.9%28.5%38.8%
Stroke63642.3%40.0%45.2%
Osteoarthritis54961.7%60.1%61.0%
Depressive disorders1,27763.2%65.1%60.4%
Rheumatoid arthritis45079.4%80.1%72.1%
Migraine29083.9%83.9%68.9%

Some trials are counted under more than one condition: 5,578 trial–condition entries, 5,198 distinct trials. Very large trials can skew the "all participants" share; the median trial is shown too.

Our analysis of 5,198 ClinicalTrials.gov trials (2010–2025) that reported participants by sex, compared with GBD 2023 burden (DALYs). Studies that compare with prevalence find similar patterns (Rivera et al., JAMA Netw Open 2025).

Ratio of two sources. Sources: ClinicalTrials.gov, US National Library of Medicine; analysis by Women's Health Gaps; IHME, GBD 2023; Rivera FB et al., JAMA Netw Open 2025. Data: ctgov_vs_gbd_summary.csv, ctgov_trials_sex_by_condition.csv

Sources

  1. Causes of Death, Australia, 2025. Australian Bureau of Statistics, 2026.
  2. Differences in management and outcomes for men and women with ST-elevation myocardial infarction (Khan E et al.). Medical Journal of Australia, 209(3), 2018.
  3. Participation of women in cardiovascular trials from 2017 to 2023: a systematic review (Rivera FB et al.). JAMA Network Open, 8(8), 2025.
  4. Heart Foundation partners with Her Heart (media release). Heart Foundation, 2025.
  5. Differences between sexes in STEMI treatment and outcomes with contemporary primary PCI (Savage ML et al.). Catheterization and Cardiovascular Interventions, 104(5), 2024.
  6. Women and cardiovascular disease: risk factors and warning signs. Heart Foundation.
  7. What is heart disease?. Heart Foundation.

Last reviewed: [NOT YET REVIEWED]